# NRG1

## Overview
Neuregulin 1 (NRG1) is a gene that encodes a family of proteins known as neuregulin 1, which are part of the epithelial growth factor (EGF) family of transmembrane growth factors. These proteins are characterized by their ability to interact with ErbB receptor tyrosine kinases, playing a pivotal role in cell-cell signaling. The NRG1 gene is notable for its complex structure, producing over 30 isoforms through alternative splicing, which are categorized into six types. These isoforms are involved in a wide range of biological processes, including nervous system development, cardiac morphogenesis, and epithelial cell proliferation. The neuregulin 1 proteins are crucial for synapse formation, synaptic plasticity, and the regulation of receptor subunit expression in the nervous system, as well as for cardiac and lung development. Clinically, alterations in the NRG1 gene have been implicated in various diseases, including cancers and Hirschsprung's disease, highlighting its significance in both normal physiological and pathological contexts (Law2004Neuregulin1; Falls2003Neuregulins:; Patel2000Neuregulin1).

## Structure
Neuregulin 1 (NRG1) is a glycoprotein that belongs to the family of transmembrane growth factors, specifically the epithelial growth factor (EGF) proteins. It is characterized by a variety of isoforms, with over 30 identified, grouped into six types: I, II, III, IV, V, and VI. These isoforms are produced through alternative splicing, resulting in proteins with distinct structures and functions (gonkowski2024neuregulin).

The primary structure of NRG1 includes an EGF-like domain, which is crucial for receptor activation and intracellular signaling. This domain is present in all isoforms and is essential for binding to ErbB receptor tyrosine kinases (Fleck2013Dual). The secondary structure of NRG1 type III includes two transmembrane domains, forming a hairpin-like structure with the EGF-like domain in its extracellular loop (Fleck2013Dual).

NRG1 isoforms undergo post-translational modifications such as glycosylation, which can affect their migration patterns in Western blot analysis (Fleck2013Dual). The tertiary structure of NRG1 type III is influenced by its cysteine-rich domain (CRD), which overlaps with the N-terminal transmembrane helix (Wang2023A). The quaternary structure is not explicitly detailed in the provided context. 

The processing of NRG1 involves proteolytic cleavage by enzymes such as BACE1, ADAM10, and ADAM17, which release the EGF-like domain, allowing it to function in paracrine signaling (Fleck2013Dual). This cleavage is crucial for the protein's role in signaling pathways, including those involved in myelination (Fleck2013Dual).

## Function
Neuregulin 1 (NRG1) is a gene that encodes a family of proteins involved in critical cell-cell signaling processes. These proteins interact with receptor tyrosine kinases of the ErbB family, particularly ErbB3 and ErbB4, to form homo- or heterodimers that activate intracellular signaling pathways. This signaling is essential for various cellular processes, including proliferation, apoptosis, migration, differentiation, and adhesion (Falls2003Neuregulins:).

NRG1 plays a significant role in the development and function of the nervous system and heart. In the nervous system, NRG1 is crucial for synapse formation, synaptic plasticity, and the regulation of receptor subunit expression. It influences the differentiation, proliferation, and migration of Schwann cells and neurons, and is expressed in various regions of the adult human brain, including the prefrontal cortex, hippocampus, and cerebellum (Law2004Neuregulin1).

In cardiac development, NRG1 is involved in cardiac morphogenesis, as evidenced by defects in heart development in mice with targeted mutations in the NRG1 gene (Falls2003Neuregulins:). NRG1 also plays a role in lung development, promoting epithelial cell proliferation and differentiation through interactions with HER2 and HER3 receptors (Patel2000Neuregulin1).

## Clinical Significance
Mutations and alterations in the NRG1 gene are implicated in various diseases, particularly cancers and Hirschsprung's disease (HSCR). In oncology, NRG1 fusions are identified as oncogenic drivers in several cancers, including non-small-cell lung cancer (NSCLC), pancreatic adenocarcinomas, and breast cancer. These fusions are more prevalent in invasive mucinous adenocarcinoma (IMA) of the lung and are often found in non-smokers and certain ethnic populations (Laskin2020NRG1; Rosas2021Neuregulin). NRG1 fusions activate the ERBB3 signaling pathway, promoting tumor growth and potentially leading to poor prognosis in cancers like breast cancer (Drilon2018Response; Yun2017Clinical).

In gastric cancer, NRG1 overexpression is associated with aggressive tumor characteristics and poor prognosis, suggesting its role as an independent prognostic factor (Yun2017Clinical). NRG1 is also linked to resistance to HER2-targeted therapies in breast cancer (Rosas2021Neuregulin).

In the context of Hirschsprung's disease, NRG1 has been identified as a susceptibility locus, with certain genetic variants increasing the risk of the disease, particularly in conjunction with RET gene variations (GarciaBarcelo2009Genomewide; Tang2011Mutations). These findings highlight the gene's role in the development of the enteric nervous system and its potential contribution to HSCR pathology.

## Interactions
Neuregulin 1 (NRG1) interacts with several proteins, primarily through the ErbB family of receptor tyrosine kinases. NRG1 binds to ErbB3 and ErbB4 receptors, which are crucial for its signaling functions. ErbB3, although catalytically inactive, forms heterodimers with ErbB2 to propagate signals, while ErbB4 can directly bind NRG1 and participate in signaling pathways (Buonanno2001Neuregulin; Birchmeier2008Neuregulin‐1).

In neuronal development, NRG1 is involved in the activation of the NMDA receptor subunit NR2B and the tropomyosin-related kinase receptor B (TrkB) in immature cortical neurons. This activation is mediated through the phospholipase C-gamma (PLC-γ) pathway. The interaction between TrkB and ErbB4 is essential for NRG1-induced NR2B activation, highlighting the importance of these interactions in neurodevelopmental processes (Pandya2014TrkB).

NRG1 also plays a role in the ubiquitination and degradation of ErbB3 through a protein stability cascade involving the E3 ubiquitin ligase Nrdp1 and the deubiquitinating enzyme USP8. This process is crucial for regulating ErbB3 levels and is mediated by the PI3K/Akt signaling pathway (Cao2007NeuregulinInduced).


## References


[1. (Yun2017Clinical) Sumi Yun, Jiwon Koh, Soo Kyung Nam, Jung Ok Park, Sung Mi Lee, Kyoungyul Lee, Kyu Sang Lee, Sang-Hoon Ahn, Do Joong Park, Hyung-Ho Kim, Gheeyoung Choe, Woo Ho Kim, and Hye Seung Lee. Clinical significance of overexpression of nrg1 and its receptors, her3 and her4, in gastric cancer patients. Gastric Cancer, 21(2):225–236, June 2017. URL: http://dx.doi.org/10.1007/s10120-017-0732-7, doi:10.1007/s10120-017-0732-7. This article has 25 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1007/s10120-017-0732-7)

[2. (Wang2023A) Yukai Wang, Yu Zhang, Yingxing Wang, Hong Chen, Liangjing Pan, Xufeng Liao, and Shunqi Wang. A novel form of neuregulin 1 type iii caused by n-terminal processing. Biomolecules, 13(12):1756, December 2023. URL: http://dx.doi.org/10.3390/biom13121756, doi:10.3390/biom13121756. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/biom13121756)

[3. (Buonanno2001Neuregulin) Andres Buonanno and Gerald D Fischbach. Neuregulin and erbb receptor signaling pathways in the nervous system. Current Opinion in Neurobiology, 11(3):287–296, June 2001. URL: http://dx.doi.org/10.1016/s0959-4388(00)00210-5, doi:10.1016/s0959-4388(00)00210-5. This article has 404 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/s0959-4388(00)00210-5)

[4. (Drilon2018Response) Alexander Drilon, Romel Somwar, Biju P. Mangatt, Henrik Edgren, Patrice Desmeules, Anja Ruusulehto, Roger S. Smith, Lukas Delasos, Morana Vojnic, Andrew J. Plodkowski, Joshua Sabari, Kenneth Ng, Joseph Montecalvo, Jason Chang, Huichun Tai, William W. Lockwood, Victor Martinez, Gregory J. Riely, Charles M. Rudin, Mark G. Kris, Maria E. Arcila, Christopher Matheny, Ryma Benayed, Natasha Rekhtman, Marc Ladanyi, and Gopinath Ganji. Response to erbb3-directed targeted therapy in nrg1-rearranged cancers. Cancer Discovery, 8(6):686–695, May 2018. URL: http://dx.doi.org/10.1158/2159-8290.cd-17-1004, doi:10.1158/2159-8290.cd-17-1004. This article has 147 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1158/2159-8290.cd-17-1004)

[5. (Pandya2014TrkB) Chirayu D Pandya and Anilkumar Pillai. Trkb interacts with erbb4 and regulates nrg1-induced nr2b phosphorylation in cortical neurons before synaptogenesis. Cell Communication and Signaling, July 2014. URL: http://dx.doi.org/10.1186/s12964-014-0047-9, doi:10.1186/s12964-014-0047-9. This article has 19 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12964-014-0047-9)

[6. (Fleck2013Dual) Daniel Fleck, Frauke van Bebber, Alessio Colombo, Chiara Galante, Benjamin M. Schwenk, Linnea Rabe, Heike Hampel, Bozidar Novak, Elisabeth Kremmer, Sabina Tahirovic, Dieter Edbauer, Stefan F. Lichtenthaler, Bettina Schmid, Michael Willem, and Christian Haass. Dual cleavage of neuregulin 1 type iii by bace1 and adam17 liberates its egf-like domain and allows paracrine signaling. The Journal of Neuroscience, 33(18):7856–7869, May 2013. URL: http://dx.doi.org/10.1523/jneurosci.3372-12.2013, doi:10.1523/jneurosci.3372-12.2013. This article has 106 citations.](https://doi.org/10.1523/jneurosci.3372-12.2013)

[7. (Falls2003Neuregulins:) D Falls. Neuregulins: functions, forms, and signaling strategies. Experimental Cell Research, 284(1):14–30, March 2003. URL: http://dx.doi.org/10.1016/s0014-4827(02)00102-7, doi:10.1016/s0014-4827(02)00102-7. This article has 822 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/s0014-4827(02)00102-7)

[8. (Rosas2021Neuregulin) Daniel Rosas, Luis E. Raez, Alessandro Russo, and Christian Rolfo. Neuregulin 1 gene (nrg1). a potentially new targetable alteration for the treatment of lung cancer. Cancers, 13(20):5038, October 2021. URL: http://dx.doi.org/10.3390/cancers13205038, doi:10.3390/cancers13205038. This article has 17 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/cancers13205038)

[9. (Birchmeier2008Neuregulin‐1) Carmen Birchmeier and Klaus‐Armin Nave. Neuregulin‐1, a key axonal signal that drives schwann cell growth and differentiation. Glia, 56(14):1491–1497, September 2008. URL: http://dx.doi.org/10.1002/glia.20753, doi:10.1002/glia.20753. This article has 194 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1002/glia.20753)

[10. (Law2004Neuregulin1) A.J Law, C Shannon Weickert, T.M Hyde, J.E Kleinman, and P.J Harrison. Neuregulin-1 (nrg-1) mrna and protein in the adult human brain. Neuroscience, 127(1):125–136, January 2004. URL: http://dx.doi.org/10.1016/j.neuroscience.2004.04.026, doi:10.1016/j.neuroscience.2004.04.026. This article has 125 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.neuroscience.2004.04.026)

[11. (Cao2007NeuregulinInduced) Zhongwei Cao, Xiuli Wu, Lily Yen, Colleen Sweeney, and Kermit L. Carraway. Neuregulin-induced erbb3 downregulation is mediated by a protein stability cascade involving the e3 ubiquitin ligase nrdp1. Molecular and Cellular Biology, 27(6):2180–2188, March 2007. URL: http://dx.doi.org/10.1128/MCB.01245-06, doi:10.1128/mcb.01245-06. This article has 150 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/MCB.01245-06)

12. (gonkowski2024neuregulin) Slawomir Gonkowski. Neuregulin 1 (nrg1) and its receptors in the enteric nervous system and other parts of the gastrointestinal wall. Histol Histopathol, 39:1089–1099, 2024. This article has 1 citations.

[13. (Laskin2020NRG1) J. Laskin, S.V. Liu, K. Tolba, C. Heining, R.F. Schlenk, P. Cheema, J. Cadranel, M.R. Jones, A. Drilon, A. Cseh, S. Gyorffy, F. Solca, and M. Duruisseaux. Nrg1 fusion-driven tumors: biology, detection, and the therapeutic role of afatinib and other erbb-targeting agents. Annals of Oncology, 31(12):1693–1703, December 2020. URL: http://dx.doi.org/10.1016/j.annonc.2020.08.2335, doi:10.1016/j.annonc.2020.08.2335. This article has 83 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.annonc.2020.08.2335)

[14. (GarciaBarcelo2009Genomewide) Maria-Mercè Garcia-Barcelo, Clara Sze-man Tang, Elly Sau-wai Ngan, Vincent Chi-hang Lui, Yan Chen, Man-ting So, Thomas Yuk-yu Leon, Xiao-ping Miao, Cathy Ka-yee Shum, Feng-qin Liu, Ming-yiu Yeung, Zhen-wei Yuan, Wei-hong Guo, Lei Liu, Xiao-bing Sun, Liu-ming Huang, Jin-fa Tou, You-qiang Song, Danny Chan, Kenneth M. C. Cheung, Kenneth Kak-yuen Wong, Stacey S. Cherny, Pak-chung Sham, and Paul Kwong-hang Tam. Genome-wide association study identifies nrg1 as a susceptibility locus for hirschsprung’s disease. Proceedings of the National Academy of Sciences, 106(8):2694–2699, February 2009. URL: http://dx.doi.org/10.1073/pnas.0809630105, doi:10.1073/pnas.0809630105. This article has 161 citations.](https://doi.org/10.1073/pnas.0809630105)

[15. (Tang2011Mutations) Clara Sze-Man Tang, Elly Sau-Wai Ngan, Wai-Kiu Tang, Man-Ting So, Guo Cheng, Xiao-Ping Miao, Thomas Yuk-Yu Leon, Brian Man-Chun Leung, Kenneth-Jeremy W. S. Hui, Vincent Hang-Chai Lui, Yan Chen, Ivy Hau-Yee Chan, Patrick Ho-Yu Chung, Xue-Lai Liu, Kenneth Kak-Yuen Wong, Pak-Chung Sham, Stacey S. Cherny, Paul Kwong-Hang Tam, and Maria-Mercè Garcia-Barcelo. Mutations in the nrg1 gene are associated with hirschsprung disease. Human Genetics, 131(1):67–76, June 2011. URL: http://dx.doi.org/10.1007/s00439-011-1035-4, doi:10.1007/s00439-011-1035-4. This article has 46 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s00439-011-1035-4)

[16. (Patel2000Neuregulin1) Neil V. Patel, Michael J. Acarregui, Jeanne M. Snyder, Jonathan M. Klein, Mark X. Sliwkowski, and Jeffrey A. Kern. Neuregulin-1 and human epidermal growth factor receptors 2 and 3 play a role in human lung development in vitro. American Journal of Respiratory Cell and Molecular Biology, 22(4):432–440, April 2000. URL: http://dx.doi.org/10.1165/ajrcmb.22.4.3854, doi:10.1165/ajrcmb.22.4.3854. This article has 51 citations and is from a peer-reviewed journal.](https://doi.org/10.1165/ajrcmb.22.4.3854)